Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unplanned Return to the Operating Room After Keratoplasty.

Cornea·2026
Same author

Matching-adjusted indirect comparison of acoltremon ophthalmic solution 0.003% and cyclosporine 0.05% ophthalmic emulsion for increased tear production in patients with dry eye disease.

Journal of comparative effectiveness research·2026
Same author

Atopic dermatitis and ocular surface disorders: a United States claims-based cross-sectional study.

BMC ophthalmology·2026
Same author

Intraoperative Peripheral Iridotomy for Endothelial Keratoplasty with a 22-Gauge Needle.

Eye banking and corneal transplantation·2026
Same author

Current Indications and Outcomes of Penetrating Keratoplasty in the United States: An IRIS® Registry Study.

Ophthalmology·2026
Same author

Patient-Reported Symptoms Versus Clinician-Measured Signs to Distinguish Sjogren's in Patients With Dry Eye.

Translational vision science & technology·2026
Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026
Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026
Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026
Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026
Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026
Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026
See all related articles

Related Experiment Video

Updated: May 17, 2026

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

Mucous membrane pemphigoid: recent advances.

Divya Srikumaran1, Esen K Akpek

  • 1Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Current Opinion in Ophthalmology
|October 11, 2012
PubMed
Summary
This summary is machine-generated.

Mucous membrane pemphigoid (MMP) diagnosis and management have advanced, yet ocular morbidity persists. Early detection and novel therapies are crucial for preventing vision loss from this rare blistering disease.

More Related Videos

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Related Experiment Videos

Last Updated: May 17, 2026

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Area of Science:

  • Ophthalmology
  • Dermatology
  • Immunology

Background:

  • Mucous membrane pemphigoid (MMP) is a rare autoimmune subepithelial blistering disease affecting the conjunctiva.
  • Ocular MMP frequently leads to significant vision impairment and scarring.

Purpose of the Study:

  • To review recent advancements in the diagnosis and management of ocular mucous membrane pemphigoid (MMP).
  • To highlight challenges in current treatment strategies and identify areas for future research.

Main Methods:

  • Comprehensive literature review of English-language publications since May 2011.
  • Analysis of diagnostic techniques, immunopathology, and therapeutic interventions for MMP.

Main Results:

  • Distinct MMP subgroups identified, including antiepiligrin MMP associated with malignancies.
  • Immunomodulators (mycophenolate mofetil) and biologics (rituximab) show efficacy in disease control.
  • Advanced disease at presentation necessitates regenerative techniques (stem cell therapy) and surgical interventions (keratoprosthesis) for vision restoration.

Conclusions:

  • Despite treatment advances, persistent ocular morbidity underscores diagnostic challenges and delayed treatment initiation.
  • The absence of overt inflammation in some patients complicates early diagnosis and treatment, leading to progressive scarring.
  • Surgical management of MMP complications remains difficult with high long-term failure rates.